NASDAQ:BBIO | EBITDA | BridgeBio Pharma, Inc.

Complete source-backed ebitda history.

Available history
2019-12-31 to 2026-03-31
Data captured

Historical EBITDA

DateEBITDA
2026-03-31-$104.77M
2025-12-31-$138.13M
2025-03-31-$103.09M
2024-12-31-$224.66M
2024-03-31$1.94M
2023-12-31-$175.83M
2023-03-31-$124.53M
2022-12-31-$127.57M
2022-03-31-$171.79M
2021-12-31-$164.09M
2021-03-31-$166.94M
2020-12-31-$127.05M

Annual EBITDA

DateEBITDA
2025-12-31-$517.98M
2024-12-31-$586.9M
2023-12-31-$600.88M
2022-12-31-$505.43M
2021-12-31-$570.79M
2020-12-31-$473.03M
2019-12-31-$265.38M